Pfizer's PTAB Appeal 'At War With Itself,' Fed. Circ. Told
Pfizer's bid to overturn a pair of Patent Trial and Appeal Board rulings refusing to invalidate purifying antibodies patents owned by a Hoffmann-La Roche Ltd. unit is "at war with itself...To view the full article, register now.
Already a subscriber? Click here to view full article